Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
SeqLL Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS
Ticker
Exchange
SIC #
Website
Latest Ticker
SQL
Nasdaq
3826
http://seqll.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for SeqLL Inc
SeqLL Announces Fourth Quarter and Year End 2022 Financial Results
- Mar 17th, 2023 12:30 pm
Volatile SQL Stock Could Give Risk-Tolerant Investors a Wild Ride
- Feb 22nd, 2023 11:00 am
SeqLL Inc. Announces Closing of $1.8 Million Registered Direct Offering
- Feb 15th, 2023 9:00 pm
SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering
- Feb 13th, 2023 1:30 pm
SeqLL stock rockets on heavy volume again, in wake of 2-year development pact with FBI
- Feb 10th, 2023 2:21 pm
SeqLL Announces CRADA with the FBI
- Feb 7th, 2023 12:30 pm
SEQLL INC. GRANTED SECOND 180-DAY EXTENSION BY NASDAQ REGARDING MINIMUM BID REQUIREMENTS
- Dec 22nd, 2022 9:00 pm
Brian Paras joins SeqLL as Chief Business Officer
- Dec 13th, 2022 2:25 pm
SeqLL Third Quarter 2022 Earnings: US$0.078 loss per share (vs US$0.089 loss in 3Q 2021)
- Nov 11th, 2022 11:07 am
SeqLL Provides Third Quarter 2022 Financial Results
- Nov 10th, 2022 3:08 am
UPDATE -- SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology
- Sep 13th, 2022 3:56 pm
SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology
- Sep 12th, 2022 12:00 pm
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
- Sep 6th, 2022 12:01 pm
SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements
- Jun 24th, 2022 8:05 pm
SeqLL’s Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal
- Jun 13th, 2022 12:00 pm
SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
- May 13th, 2022 12:00 pm
SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
- Mar 30th, 2022 9:06 pm
SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
- Mar 24th, 2022 8:05 pm
Scroll